Research

Persistent Growth-promoting effects of vosoritide in children with achondroplasia are accompanied by improvements in physical and social aspects of health related quality of life

Publication of impact on health-related quality of life from 3 year data with vosoritide. These data suggest that after 3 years of treatment, vosoritide demonstrates a…

Persistent Growth-promoting effects of vosoritide in children with achondroplasia are accompanied by improvements in physical and social aspects of health related quality of life

Proposed Endocrine Funding Priorities for the NICHD Strategic Plan: Expert Opinion from the Pediatric Endocrine Society

Increasing Minority Participation in Clinical Research

Get Involved

Join a Special Interest Group

Join PES

Mentoring Program

Explore PES Grants & Scholarships

Learn More About PES!